Wayrilz

Active Ingredient(s): Rilzabrutinib
FDA Approved: * August 29, 2025
Pharm Company: * GENZYME CORP
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Wayrilz 400 mg Oral Tablet, Film Coated
NDC: 58468-0251
Labeler:
Genzyme Corporation